#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular calcification Salivary gland cancer Chronic lymphocytic leukaemia recurrent Pseudoxanthoma elasticum Burkitt's lymphoma refractory Anal squamous cell carcinoma Squamous cell carcinoma of the cervix Chordoma Nephroblastoma Germ cell cancer Dilated cardiomyopathy ROHHAD syndrome Thalassaemia alpha Hypersensitivity pneumonitis Oesophageal adenocarcinoma stage II More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Trials in Disease Synovial sarcoma metastatic – Trials in Disease Bronchiolitis obliterans syndrome – Life with Disease Nephrotic syndrome – Treatment Systemic sclerosis pulmonary – Diagnostics Biotinidase deficiency – Trials in Disease Basal cell naevus syndrome – Treatment Testicular leiomyosarcoma – Treatment Systemic mastocytosis – Life with Disease Rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pevonedistat Zofenopril Calcium Op-1250 Galcanezumab Mdna11 Sodium Cetrorelix Defactinib A/H1N1 INFLUENZA VACCINE ZUNIBERGENE ROCPARVOVEC VERCIRNON Paclitaxel Obaluronate Padeliporfin Tavapadon Nitrofurantoin [18F]Alf-Nota-Octreotide Zinc Oxide Streptococcus Pneumoniae Nortriptyline Hydrochloride SRSD107 More therapies…

    Learn about Your Condition

    Neutropenia Anal cancer stage II Androgenetic alopecia Von Willebrand's disease Renal cancer stage IV Schizophrenia Gallbladder cancer Oesophageal carcinoma Marfan's syndrome Influenza Tooth loss Acute myocardial infarction Red blood cell abnormality Injection site pain Lymphangioleiomyomatosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • Study to Compare Non-Radioactive Methods for Measuring Kidney Function in Patients with Chronic Kidney Disease Using Sodium Iotalamate, Sodium Iodohippurate, and Iohexol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Iotalamate (125I)
    • Clemastine
    • Iohexol
    The Netherlands

  • Study on the Effects of Amiloride in Patients with Chronic Kidney Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Amiloride Hydrochloride Dihydrate
    • Placebo
    Denmark

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Atrial fibrillation
    • Chronic kidney disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    • Chronic kidney disease
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dapagliflozin
    Germany

  • A study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • BI 456906
    • SURVODUTIDE
    Germany The Netherlands Spain
Previous Page
1 … 3 4 5 6 7 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!